Raederstorff
Daniel Raederstorff, Flaxianden DE
Patent application number | Description | Published |
---|---|---|
20110014308 | NOVEL COMPOSITIONS AND USE THEREOF FOR THE TREATMENT, CO-TREATMENT OR PREVENTION OF INFLAMMATORY DISORDERS. - The present invention relates to novel compositions comprising hydroxytyrosol and chondroitin as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders. | 01-20-2011 |
Daniel Raederstorff, Brunstatt FR
Patent application number | Description | Published |
---|---|---|
20090192218 | USE OF PHTHALIDE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DIABETES MELLITUS - The present invention relates to the use of a compound as effective agent for the prevention or treatment of diabetes mellitus in a mammal. Said compounds being selected from the group of phthalide derivatives and exhibit excellent blood glucose lowering effects and thus are effective agents in the prevention or treatment of diabetes mellitus in mammals. | 07-30-2009 |
20090221694 | Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone - Compositions comprising epigallocatechin gallate and 4-(4-hydroxyphenyl)-2-butanone may be used for treatment or prevention of obesity or conditions associated with obesity such as non-insulin-dependent diabetes mellitus (NIDDM, type II) and syndrome X. The compositions may find use in the nutritional field as a supplement to food and beverages, as well as a pharmaceutical formulation. | 09-03-2009 |
Daniel Raederstorff, Flaxlanden DE
Patent application number | Description | Published |
---|---|---|
20090203773 | Compounds for the Treatment of Non-Autoimmune Type 2 Diabetes Mellitus and/or Syndrome X - The present invention relates to compounds of the formula (I); wherein R | 08-13-2009 |
20140162976 | COMPOSITIONS COMPRISING HYDROXYTYROSOL AND CHONDROITIN AND USE THEREOF FOR THE TREATMENT, CO-TREATMENT OR PREVENTION OF INFLAMMATORY DISORDERS - The present invention relates to novel compositions comprising hydroxytyrosol and chondroitin as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders. | 06-12-2014 |
Daniel Raederstorff, Flaxlande FR
Patent application number | Description | Published |
---|---|---|
20130059920 | HYDROXYTYROSOL BENEFITS MUSCLE DIFFERENTIATION AND MUSCLE CONTRACTION AND RELAXATION - This invention is related to the use of hydroxytyrosol (“HT”), or an olive juice extract containing hydroxytyrosol as an agent to improve muscle differentiation and thus improve or maintain the body's adaptation to exercise. It is also related to the use of hydroxytyrosol (“HT”), or an olive juice extract containing hydroxytyrosol as an agent to improve calcium signaling and to improve skeletal muscle contraction and relaxation. It also relates to pharmaceutical and nutraceutical compositions useful for conditions characterized by altered muscle differentiation especially under inflammatory conditions, such as delayed onset muscle soreness subsequent to strenuous exercise or sarcopenia. | 03-07-2013 |